Activity of camptothecin, harringtonin, cantharidin and curcumae in the human tumor stem cell assay
- 1 February 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (2), 263-270
- https://doi.org/10.1016/0277-5379(83)90425-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- NEW DRUGS IN OVARIAN-CANCER AND MALIGNANT-MELANOMA - INVITRO PHASE-II SCREENING WITH THE HUMAN-TUMOR STEM-CELL ASSAY1981
- INHIBITION OF HUMAN-MELANOMA COLONY FORMATION BY RETINOIDS1979
- PREPARATION OF PERMANENT SLIDES OF INTACT SOFT-AGAR COLONY CULTURES OF HEMATOPOIETIC AND TUMOR STEM-CELLS1979
- CONTROLLED CLINICAL STUDIES WITH AN ANTIDOTE AGAINST THE UROTOXICITY OF OXAZAPHOSPHORINES - PRELIMINARY-RESULTS1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Antitumor Alkaloids from Cephalotaxus harringtonia: Structure and ActivityJournal of Pharmaceutical Sciences, 1972
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966